Time requirements for perioperative glucose management using fully closed‐loop versus standard insulin therapy: A proof‐of‐concept time–motion study
Authors' conclusion
The use of fully automated closed-loop insulin delivery for inpatient glucose management has the potential to alleviate the workload of diabetes management in an environment with adequately trained staff.
Study context
- Population
- Theoretical scenarios of elective minor and major abdominal surgery patients receiving insulin from hospital admission (pre-/intra-operatively, intermediate care unit, general wards)each task measured 20 times
- Comparison
- Fully closed-loop (FCL) vs standard insulin therapy for perioperative glucose management
- Outcome
- Cumulative staff time required for perioperative blood glucose management
Methodological detailsproof-of-concept, theoretical scenarios, staff shadowing, Task durations measured by shadowing hospital staff; average duration combined with guideline frequency
- Proof-of-concept
- Theoretical scenarios
- Staff shadowing
- Task durations measured by shadowing hospital staff; average duration combined with guideline frequency
Main finding
As reported in the abstract
Total staff time for perioperative glucose management
FCL reduced time required vs standard insulin therapy across all care periods and both pathways (range)
2.1-4.5
Major abdominal surgery: FCL vs standard insulin therapy
248.5 min vs 753.9 min
Minor abdominal surgery: FCL vs standard insulin therapy
68.6 min vs 133.2 min
Original publication
Time requirements for perioperative glucose management using fully closed‐loop versus standard insulin therapy: A proof‐of‐concept time–motion study. Diabet Med. Published 25 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →